Hydrogenology
Hydrogenology editorial study record

Hydrogen may inhibit collagen-induced platelet aggregation: an ex vivo and in vivo study

Takeuchi S, Wada K, Nagatani K, Osada H, Otani N, Nawashiro H. · Intern Med. 2012;51(11):1309–1313.

PreclinicalInhaled H₂Published 2012
Study record, not medical adviceThis page reports one source and Hydrogenology’s source-text extraction. It does not establish that molecular hydrogen is effective, safe or appropriate for any person. Human, animal and laboratory evidence must not be treated as equivalent.
Source and classification

What kind of evidence is this?

Evidence stream

Preclinical

Reported design

Human ex-vivo and controlled rat study

Research topic

Cardiovascular and circulatory health

Administration classification

Inhaled H₂

Study result signal

Positive laboratory and preclinical signal.

Outcome type

Ex-vivo and animal platelet-function outcomes.

Reported in the source

Methods at a glance

Population or model

Blood samples from human volunteers and rats exposed to hydrogen gas or hydrogen-rich saline.

Sample

Human ex-vivo and rat experimental samples; arm counts were checked in the article.

Duration

Acute laboratory and animal exposures.

Intervention

Hydrogen inhalation in rats and hydrogen-rich saline or hydrogen exposure in platelet experiments.

Hydrogen form

Inhaled H₂ gas and H₂ dissolved in saline.

H₂ specification

Article-specific gas and solution exposures.

H₂ flow

Reported in the full methods for the rat exposure.

O₂ delivered with H₂

Gas exposure used the article’s reported carrier mixture.

Comparator

Air or vehicle controls.

Reported, not endorsed

Outcomes and reported result

Outcomes measured

Platelet aggregation and related laboratory measures.

Reported result

The article reports suppressed platelet aggregation after the H₂ exposures in the tested systems.

Results-extraction completeness

The full article methods, intervention, outcomes, positive and null findings, funding and conflict statements were checked.

A reported association, difference or mechanism is not automatically a clinical benefit. Null findings, outcome type, study design and precision all matter.

Interpretation limits

Cautions and applicability

Design and reporting cautions

The human component is ex vivo, not a clinical treatment study; the animal and laboratory findings do not establish patient outcomes.

Applies directly to

The tested samples and rat protocol only.

Preliminary appraisal framework

SYRCLE animal-study tool — preliminary

Preliminary risk-of-bias status

Some concerns

Appraisal rationale

Laboratory comparators were present, but sampling, allocation and blinded assessment were incompletely reported.

Appraisal domains

Sequence generation checked where reported · Allocation concealment generally unclear · Personnel blinding generally unclear · Outcome-assessor blinding generally unclear · No prospectively registered analysis plan identified

No single-study GRADE certainty rating is assigned. Certainty is assessed by important outcome across a complete eligible evidence set, not by attaching a final grade to one source.

Provenance

Sources and record status

Identifiers

PMID: 22687834 · DOI: 10.2169/internalmedicine.51.7161

Publisher access

A free publisher or repository full article was checked.

Extraction basis

Publisher or repository full article and bibliographic record; checked 10 August 2026.

Record revision

2026-08-10